Stellar Biotechnologies Advances Strategic Plan to Secure Key Production Region
11 janv. 2017 07h30 HE
|
Stellar Biotechnologies, Inc.
LOS ANGELES, CA--(Marketwired - Jan 11, 2017) - Stellar Biotechnologies, Inc. (NASDAQ: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy development pipelines...
Stellar Biotechnologies to Present at Biotech Showcase Conference
04 janv. 2017 07h30 HE
|
Stellar Biotechnologies, Inc.
LOS ANGELES, CA--(Marketwired - Jan 4, 2017) - Stellar Biotechnologies, Inc. (NASDAQ: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy development pipelines...
Stellar Biotechnologies Reports Fiscal Year 2016 Financial Results
14 déc. 2016 16h05 HE
|
Stellar Biotechnologies, Inc.
LOS ANGELES, CA--(Marketwired - Dec 14, 2016) - Stellar Biotechnologies, Inc. (NASDAQ: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy development pipelines...
Stellar Biotechnologies Announces Fiscal Year 2016 Corporate Update Conference Call
12 déc. 2016 07h45 HE
|
Stellar Biotechnologies, Inc.
LOS ANGELES, CA--(Marketwired - Dec 12, 2016) - Stellar Biotechnologies, Inc. (NASDAQ: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy development pipelines...
Stellar Biotechnologies Appoints Pharma and Capital Markets Experts to Board of Directors
09 déc. 2016 07h45 HE
|
Stellar Biotechnologies, Inc.
LOS ANGELES, CA--(Marketwired - Dec 9, 2016) - Stellar Biotechnologies, Inc. (NASDAQ: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy development pipelines...
Stellar Biotechnologies to Present at the LD Micro Main Event Investor Conference
01 déc. 2016 07h45 HE
|
Stellar Biotechnologies, Inc.
LOS ANGELES, CA--(Marketwired - Dec 1, 2016) - Stellar Biotechnologies, Inc. (NASDAQ: SBOT), the leader in sustainable manufacture of a key protein utilized in multiple immunotherapy development...
Stellar Board Member and Pharma Expert to Join Executive Team
24 oct. 2016 07h30 HE
|
Stellar Biotechnologies, Inc.
LOS ANGELES, CA--(Marketwired - Oct 24, 2016) - Stellar Biotechnologies, Inc. (NASDAQ: SBOT), the leader in sustainable manufacture of a key protein utilized in multiple immunotherapy development...
Stellar Appoints Investor Relations Executive to Management Team to Support Its Continuing Scale-Up
05 oct. 2016 08h30 HE
|
Stellar Biotechnologies, Inc.
LOS ANGELES, CA--(Marketwired - Oct 5, 2016) - Stellar Biotechnologies, Inc. (NASDAQ: SBOT), the leader in sustainable manufacture of a key protein utilized in multiple immunotherapy development...
Stellar Biotechnologies to Present at International Aquaculture Symposium
21 sept. 2016 08h30 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - Sep 21, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH),...
Stellar Biotechnologies to Present at the 18th Rodman & Renshaw 2016 Annual Global Investment Conference
06 sept. 2016 08h30 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - Sep 6, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"),...